Vincerx Pharma Stock Market Value
| VINC Stock | USD 0.28 0.02 7.69% |
| Symbol | Vincerx |
Vincerx Pharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Return On Assets (0.66) | Return On Equity (1.42) |
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vincerx Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vincerx Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vincerx Pharma.
| 06/08/2023 |
| 11/29/2024 |
If you would invest 0.00 in Vincerx Pharma on June 8, 2023 and sell it all today you would earn a total of 0.00 from holding Vincerx Pharma or generate 0.0% return on investment in Vincerx Pharma over 540 days. Vincerx Pharma is related to or competes with Cue Biopharma, Eliem Therapeutics, Inhibrx, and Molecular Partners. Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet med... More
Vincerx Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vincerx Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vincerx Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 47.76 | |||
| Value At Risk | (7.32) | |||
| Potential Upside | 5.71 |
Vincerx Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vincerx Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vincerx Pharma's standard deviation. In reality, there are many statistical measures that can use Vincerx Pharma historical prices to predict the future Vincerx Pharma's volatility.| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (1.51) | |||
| Total Risk Alpha | (2.35) | |||
| Treynor Ratio | (1.37) |
Vincerx Pharma Backtested Returns
Vincerx Pharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.2, which indicates the firm had a -0.2% return per unit of risk over the last 3 months. Vincerx Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vincerx Pharma's Coefficient Of Variation of (465.16), variance of 41.15, and Risk Adjusted Performance of (0.16) to confirm the risk estimate we provide. The entity has a beta of 1.01, which indicates a somewhat significant risk relative to the market. Vincerx Pharma returns are very sensitive to returns on the market. As the market goes up or down, Vincerx Pharma is expected to follow. At this point, Vincerx Pharma has a negative expected return of -1.29%. Please make sure to validate Vincerx Pharma's skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Vincerx Pharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.08 |
Virtually no predictability
Vincerx Pharma has virtually no predictability. Overlapping area represents the amount of predictability between Vincerx Pharma time series from 8th of June 2023 to 4th of March 2024 and 4th of March 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vincerx Pharma price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Vincerx Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 3.51 |
Vincerx Pharma lagged returns against current returns
Autocorrelation, which is Vincerx Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vincerx Pharma's stock expected returns. We can calculate the autocorrelation of Vincerx Pharma returns to help us make a trade decision. For example, suppose you find that Vincerx Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vincerx Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vincerx Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vincerx Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vincerx Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Vincerx Pharma Lagged Returns
When evaluating Vincerx Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vincerx Pharma stock have on its future price. Vincerx Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vincerx Pharma autocorrelation shows the relationship between Vincerx Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Vincerx Pharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vincerx Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vincerx Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vincerx Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vincerx Pharma Stock:Check out Vincerx Pharma Correlation, Vincerx Pharma Volatility and Vincerx Pharma Alpha and Beta module to complement your research on Vincerx Pharma. For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Vincerx Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.